You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Celecoxib - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for celecoxib and what is the scope of freedom to operate?

Celecoxib is the generic ingredient in three branded drugs marketed by Gd Searle, Acic Pharms, Alembic Pharms Ltd, Amneal Pharms, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Cipla, Cspc Ouyi, Jubilant Generics, Lupin Ltd, Macleods Pharms Ltd, Micro Labs, Mylan, Nanjing, Qingdao Baheal Pharm, Sciegen Pharms Inc, Teva, Tianjin Tianyao, Torrent, Umedica Labs Pvt Ltd, Watson Labs Inc, Yiling, and Dr Reddys, and is included in twenty-four NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Celecoxib has twenty-three patent family members in twelve countries.

There are twenty-six drug master file entries for celecoxib. Fifty suppliers are listed for this compound.

Drug Prices for celecoxib

See drug prices for celecoxib

Drug Sales Revenue Trends for celecoxib

See drug sales revenues for celecoxib

Recent Clinical Trials for celecoxib

Identify potential brand extensions & 505(b)(2) entrants

Imperial College LondonPhase 4
BC Children's Hospital Research InstitutePhase 2
International Obsessive-Compulsive Disorder FoundationPhase 2

See all celecoxib clinical trials

Pharmacology for celecoxib
Medical Subject Heading (MeSH) Categories for celecoxib
Paragraph IV (Patent) Challenges for CELECOXIB
Tradename Dosage Ingredient NDA Submissiondate
CELEBREX CAPSULE;ORAL celecoxib 020998 2008-03-21

US Patents and Regulatory Information for celecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd CELECOXIB celecoxib CAPSULE;ORAL 202240-004 Jun 9, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Watson Labs Inc CELECOXIB celecoxib CAPSULE;ORAL 200562-004 Feb 11, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for celecoxib

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-002 Dec 31, 1998   Start Trial   Start Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-003 Aug 29, 2002   Start Trial   Start Trial
Gd Searle CELEBREX celecoxib CAPSULE;ORAL 020998-004 Dec 15, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Supplementary Protection Certificates for celecoxib

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0731795 10075033 Germany   Start Trial PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.